Related references
Note: Only part of the references are listed.Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1
Wei Hong et al.
ANTIVIRAL RESEARCH (2014)
Three-Dimensional Structure and Interaction Studies of Hepatitis C Virus p7 in 1,2-Dihexanoyl-sn-glycero-3-phosphocholine by Solution Nuclear Magnetic Resonance
Gabriel A. Cook et al.
BIOCHEMISTRY (2013)
Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus
Wei Hong et al.
BIOMATERIALS (2013)
Structure and mechanism of maximum stability of isolated alpha-helical protein domains at a critical length scale
Zhao Qin et al.
EUROPEAN PHYSICAL JOURNAL E (2013)
Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived from GB Virus A NS5A
Xiuying Liu et al.
JOURNAL OF VIROLOGY (2013)
Subcellular Localization and Function of an Epitope-Tagged p7 Viroporin in Hepatitis C Virus-Producing Cells
Gabrielle Vieyres et al.
JOURNAL OF VIROLOGY (2013)
Unusual architecture of the p7 channel from hepatitis C virus
Bo OuYang et al.
NATURE (2013)
Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment
Juliane Gentzsch et al.
PLOS PATHOGENS (2013)
PD 404,182 Is a Virocidal Small Molecule That Disrupts Hepatitis C Virus and Human Immunodeficiency Virus
Ana Maria Chamoun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis
Jungjoo Yoon et al.
ANTIVIRAL RESEARCH (2011)
Secondary structure, dynamics, and architecture of the p7 membrane protein from hepatitis C virus by NMR spectroscopy
Gabriel A. Cook et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
New direct-acting antivirals' combination for the treatment of chronic hepatitis C
Tarik Asselah et al.
LIVER INTERNATIONAL (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HSV Neutralization by the Microbicidal Candidate C5A
Lot de Witte et al.
PLOS ONE (2011)
A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry
R. Liu et al.
ANTIVIRAL RESEARCH (2010)
NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus
Roland Montserret et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepatitis C Virus P7-A Viroporin Crucial for Virus Assembly and an Emerging Target for Antiviral Therapy
Eike Steinmann et al.
VIRUSES-BASEL (2010)
Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus
Michael D. Bobardt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A virocidal arnphipathic α-helical peptide that inhibits hepatitis C virus infection in vitro
Guofeng Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Replication of hepatitis C virus
Darius Moradpour et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Robust hepatitis C virus infection in vitro
J Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Resistance to enfuvirtide, the first HIV fusion inhibitor
ML Greenberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Peptides containing membrane-transiting motifs inhibit virus entry
H Bultmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Share Paper
